18F-FDG与18F-氟昔洛韦在生化复发前列腺腺癌背景下的低分化肺腺癌中摄取
18F-FDG and 18F-Fluciclovine Uptake in Poorly Differentiated Lung Adenocarcinoma in the Setting of Biochemically Recurrent Prostatic Adenocarcinoma.
PubMed 文献 · Clin Nucl Med · 2022-09-06
一名64岁有Gleason 7(3+4)pT2cN0前列腺腺癌前列腺切除术后病史的男性,因生化复发接受氟昔洛韦PET/CT,显示右肺上叶毛刺状孤立性肺结节呈示踪剂 avid 摄取;随后FDG PET/CT显示该结节高代谢。细针穿刺符合原发性肺腺癌,右肺上叶切除术后确诊为低分化肺腺癌。
要点
- 氟昔洛韦PET/CT在前列腺癌生化复发评估中可发现肺结节示踪剂摄取。
- FDG PET/CT显示该肺结节高代谢。
- 病理确诊为原发性低分化肺腺癌。
核心结论
- 在生化复发前列腺腺癌背景下,右肺上叶毛刺状孤立性肺结节在氟昔洛韦PET/CT上呈示踪剂 avid 摄取,并在FDG PET/CT上呈高代谢,最终病理确诊为原发性低分化肺腺癌。
研究设计与样本
- 病例报告:一名64岁有Gleason 7(3+4)pT2cN0前列腺腺癌前列腺切除术后病史的男性。
主要发现
- 氟昔洛韦PET/CT显示右肺上叶毛刺状孤立性肺结节呈示踪剂 avid 摄取。
- 随访FDG PET/CT显示右肺上叶毛刺状孤立性肺结节高代谢。
- 细针穿刺符合原发性肺腺癌;右肺上叶切除术后确诊为低分化肺腺癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 64-year-old man with a history of Gleason 7 (3 + 4) pT2cN0 prostatic adenocarcinoma status post prostatectomy underwent a fluciclovine PET/CT that showed a tracer-avid right upper lobe spiculated solitary pulmonary nodule. Follow-up FDG PET/CT showed a hypermetabolic right upper lobe spiculated solitary pulmonary nodule. Fine-needle aspiration was consistent with primary lung adenocarcinoma. Subsequently, right upper lobectomy was performed, and poorly differentiated lung adenocarcinoma was confirmed.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Trak J, Hasanovic A, Gavane S, et al. 18F-FDG and 18F-Fluciclovine Uptake in Poorly Differentiated Lung Adenocarcinoma in the Setting of Biochemically Recurrent Prostatic Adenocarcinoma. Clin Nucl Med. 2022. PMID: 36342794. doi:10.1097/RLU.0000000000004387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。